News and Press Releases
September 6, 2011: ALS
Biopharma announces that it was been selected as a finalist in the Philadelphia
Business Journal Life Sciences Award program.
March 24, 2011: ALS Biopharma is pleased to announce that the company has been granted orphan drug designationby the U.S. Food and Drug Administration for heat shock protein Hsp70 for the treatment of amyotrophic lateral sclerosis.
March 11, 2011: ALS Biopharma, LLC reports that MDA Venture
Philanthropy has awarded the company a grant of $250,000.
January 27, 2011: Alzheimer's Drug Discovery Foundation Funds ALS Biopharma, LLC to Develop Small Molecules for Alzheimer's Disease
September 27, 2010: ALS Biopharma, LLC Established Strategic Alliance with Vybion
June 25, 2010: ALS Biopharma, LLC announced liscensing agreement with Wake Forest University Baptist Medical Center covering the use of the heat shock proteins for the treatment of Amyotrophic Lateral Scelrosis
